HYPERTENSIVE MEDICATIONS ON QUALITY OF LIFE IN HYPERTENSIVE PATIENTS A COMPARATIVE ASSESSMENT
Syed Azharullah Quadri*, Pawan Kumar, Mohammed Zubair Ahmed, Syed Fayyazuddin, Md. Ismail Zubair, Mohd Ateeq Ur Rehman, Mohammed Majid Iqbal
ABSTRACT
The key impartial to survey the quality of life in Hypertension patients and its associated factors among hypertensive patients. A cross-sectional education was carried out from September 2024 to March 2025 to investigate hypertensive patients’ treatment who are visiting Hospital with an antihypertensive prescription were enrolled for the study. A total of 500 patients were included in this education, among which 273 were male 54.6% & 227, 45.4% were female. In 500 patients, 121 patients were treated with monotherapy. In that 45.82% of patients were treated with Atenolol, 61.11% of patients were treated with losartan. In combination therapy most commonly used was double therapy 43.20% followed by triple therapy 15.80%. The first choice is Beta blocker 69.40% followed by Calcium Channel Blockers 59.60% was most prescribed class of drug followed by Angiotensin Receptor Blockers. In our study the final conclusion of the study reveals that Beta blocker as most prescribed class of antihypertensive and Atenolol was the most prescribed antihypertensive. In our study, most of the patients were treated with combination therapy in that double drug therapy was most common. There is a chance of various medication errors, development of adverse drug reaction as the 138 of patients belong to age above 60 years and chances of getting error also increases as combination therapy is most used. Therefore, close monitoring is required for such patients. During our discussion with patients we suggested for Lifestyle changes, it can help lower high blood pressure. Include, eating a healthy, low-salt diet, losing weight, being physically active and quitting tobacco & Alcohol.
[Full Text Article] [Certificate Download]

